Search This Blog

Thursday, February 28, 2013

AmerisourceBergen Announces Results of Annual Meeting of Stockholders

News Release:

AmerisourceBergen Announces Results of Annual Meeting of Stockholders

NAPLES, Fla.--(BUSINESS WIRE)--Feb. 28, 2013-- At the AmerisourceBergen Corporation (NYSE: ABC) annual meeting of stockholders, held today in Naples, Company stockholders elected eight directors to serve for a one-year term: Steven H. Collis, Douglas R. Conant, Richard W. GochnauerRichard C. GozonEdward E. HagenlockerKathleen W. HyleMichael J. Long, and Henry W. McGee. In addition, stockholders also ratified the appointment of Ernst & Young as the Company's independent registered public accounting firm for fiscal year 2013. The Company also announced the results of an advisory vote in which stockholders approved the compensation of the Company's named executive officers as disclosed in the Company’s 2013 proxy statement.
During the meeting, AmerisourceBergen's President and Chief Executive Officer, Steven H. Collis, gave an overview of the Company's activities and its results of operations from fiscal year 2012 and the first fiscal quarter of 2013.
Following the meeting, Charles H. Cotros, an AmerisourceBergen board member since 2002, retired. “I want to thank Charles for his eleven years of outstanding service to AmerisourceBergen,” said Richard C. Gozon, Chairman of the Board of Directors. “We will miss his insight and counsel, and we wish him all the best in his retirement.”
The AmerisourceBergen Board of Directors is comprised of nine members, all of whom are independent directors, except President and Chief Executive Officer, Steven H. Collis. Detailed biographies for all board members are available in the Company's 2013 proxy statement and on its website www.amerisourcebergen.com.
About AmerisourceBergen
AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United StatesCanadaand selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from niche premium logistics and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With over $80 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 14,500 people.AmerisourceBergen is ranked #29 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.